IU ICO is having a great time at Rally! Come check out our booth today to experience virtual reality demos and learn how IU Research is pushing the boundaries! #Rally #event #IUICO #IUResearch #VR #Demo
IU Innovation and Commercialization Office
Higher Education
Indianapolis, Indiana 1,220 followers
Advancing IU innovation to benefit Indiana and the global community
About us
The Indiana University Innovation and Commercialization Office (ICO) is tasked with the protection and commercialization of technology emanating from innovations by IU researchers. Since 1997, IU research has generated almost 3,200 inventions resulting in more than 4,800 global patent applications. These discoveries have generated more than $145 million in licensing and royalty income, including more than $115 million in funding for IU departments, labs and inventors.
- Website
-
https://ico.iu.edu/
External link for IU Innovation and Commercialization Office
- Industry
- Higher Education
- Company size
- 10,001+ employees
- Headquarters
- Indianapolis, Indiana
- Type
- Public Company
Locations
-
Primary
1220 Waterway Blvd
Suite 150
Indianapolis, Indiana 46202, US
Employees at IU Innovation and Commercialization Office
-
Lakshmi Sastry Dent
Experienced Leader with expertise in new technology development and innovation management.
-
Clayton Nicholas
Industry Partnerships
-
Melissa Franks
-
Stephanie Sellers
Associate Director of Commercialization at Indiana University Innovation and Commercialization Office
Updates
-
Six patents were awarded to Indiana University innovations! From a collaborative filtering method for electronic health records to a feeding analysis system for infants, check out these groundbreaking technologies here: https://lnkd.in/g8vK9Amg #innovation #invention #commercialization #patent #awardedpatent #IUICO #technologies
-
IU Innovation and Commercialization Office reposted this
Mark R. Kelley, PhD, discusses what makes APE1/Ref-1 a promising target for cancer therapy in a Drug Target Review article. Read the Q&A: https://ow.ly/Q0y350SW4SP. #ResearchCuresCancer
-
-
Don't forget about our Bloomington Office Hours on Thursday! Join us to talk all things licensing and commercialization: https://lnkd.in/g5ubwi8B #commercialization #IUICO #event #techtransfer #licensing #officehours
Office Hours
research.iu.edu
-
IU Innovation and Commercialization Office reposted this
Indiana University School of Medicine's groundbreaking research on preventing the decline in cognitive function in Alzheimer's patients is a testament to our state's role as a leader in advancing health outcomes. This vital work is driving innovation in neurodegenerative disease research that is positively impacting our aging population. #indiana #lifesciences #iu #alz #alzheimers #healthoutcomes #research Indiana University Bloomington Indiana University Indianapolis
Halting the decline: IU research supports historic advancement in Alzheimer’s treatment
news.iu.edu
-
IU Innovation and Commercialization Office reposted this
Exciting news from our life sciences community! Indiana University School of Medicine Dr. Harikrishna Nakshatri and his team have made a significant leap forward in breast cancer research, and their groundbreaking work on the Breast Cell Atlas is featured this month in Nature Medicine. This pioneering research maps the diverse cell types, providing invaluable insights into the complexities and origins of breast cancer. #research #iu #lifesciences #breastcancer #cancerresearch
Comprehensive atlas of normal breast cells offers new tool for understanding breast cancer origin
medicine.iu.edu
-
Another ICO Office Hours is coming up! Join us in Bloomington on August 22nd from 11:30 - 1 p.m. to have all of your commercialization questions answered: https://lnkd.in/g5ubwi8B #commercialization #techtransfer #event #IUICO #innovation #invention
Office Hours
research.iu.edu
-
NERx Biosciences, an IU faculty startup, was awarded a $2 million grant to further develop their small molecule inhibitors that target the DNA Damage Response pathway for difficult-to-treat cancers. Learn more about this groundbreaking anticancer therapeutic: https://lnkd.in/grxJPNVT #anticancer #grant #IUICO #cancertherapeutic #therapeutic #innovation #invention #technology
IU faculty-founded company awarded $2 million grant for anticancer treatment
news.iu.edu
-
Another #TechTuesday is here: Indiana University Bloomington researchers have developed a platform of anion receptors macrocycles that have a wide range of applications from energy, anti-corrosion, food, and more! Check out this revolutionary innovation here: https://lnkd.in/gyCYkR5j #technology #IUICO #invention #innovation #macrocycles #anion
| IU Flintbox
iu.flintbox.com
-
#TechTuesday: Non-small cell lung cancer (NSCLC) accounts for 81% of all lung cancer diagnoses. However, Indiana University researchers have discovered that lysosomal acid lipase (LAL) expression levels serve as an excellent biomarker for NSCLC and therapeutic target. Learn more about this technology here: https://lnkd.in/gNrbm7_s #technology #commercialization #innovation #invention #lungcancer #therapeutic #biomarker #licensing
| IU Flintbox
iu.flintbox.com